Data / Form D filings / NeXtGen Biologics, INC
NeXtGen Biologics, INC: Form D filings
NeXtGen Biologics, INC, a biotechnology company in Alachua, FL, filed 7 Form D notices with the SEC between 2014 and 2025. The latest, on September 22, 2025, reports $130,000 sold of a $5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13800 Tech City Circle, Suite 200, Alachua, FL, 32615
- Phone
- (800) 209-7190
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1620524
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | New notice | $5,000,000 | $130,000 | $4,870,000 | 3 | Jul 30, 2025 | sec.gov |
| Aug 17, 2020 | New notice | Indefinite | $100,000 | 1 | Jul 22, 2019 | sec.gov | |
| Dec 27, 2018 | New notice | Indefinite | $2,160,500 | 19 | Dec 13, 2018 | sec.gov | |
| May 24, 2017 | Amendment | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Jun 16, 2016 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
| Nov 23, 2015 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
| Sep 24, 2014 | New notice | $1,000,000 | $500,000 | $500,000 | 2 | Aug 18, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elad Levy | Director | |
| Rick Wassel | Director | |
| Gerald Kluft | Director | |
| Jonelle Toothman | Executive Officer, Director | |
| Jamie Grooms | Director | |
| Dan Hamister | Director | |
| Brian Lipke | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Sep 22, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NeXtGen Biologics, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.